Aarhus University logo / Aarhus Universitets logo
On 6 April 2022, members of MIMS participated at an online meeting with the director and group leaders of the Vilnius University Life Sciences Center (VU LSC)-EMBL Partnership for Genome Editing Technologies.
An interview with the current DANEMO communications coordinator Karen Bech-Pedersen and administrative program coordinator Maria Thykær Jensen at the Danish Research Institute of Translational Neuroscience, DANDRITE, about the first year accomplishments and future outlook of DANEMO.
The Nordic EMBL Partnership Coordination and Operations team assembled in Oslo for two days to advance joint initiatives.
Are you impressed when NASA manages to calculate the time and speed of a rocket’s trajectory? A new study shows that your brain has a “nerd centre” capable of even more complex calculations.
FIMM alumna Mari Niemi began her academic career in neuroscience and committed her postdoctoral research to COVID-19 host genetics before taking a career step into applied data science in industry.
Ieva Rauluševičiūtė is a Doctoral Research Fellow in the Mathelier group at NCMM. She recently spent one month with the groups of Dr Judith Zaugg and Dr Arnaud Krebs at the EMBL Headquarters in Heidelberg, Germany.
DANDRITE Team Leader Gilles Vanwalleghem studies communication between the gut and the brain, and how disruption of such can happen and affect immune function and behavior.
International research consortia have analyzed common and rare DNA variants in hundreds of thousands of people, revealing clearest genetic signals yet for schizophrenia risk.
NCMM is delighted to announce that Dr Biswajyoti Sahu has been recruited as a new group leader for Precision Medicine. Dr Sahu will join us in September 2022 from the University of Helsinki, Finland.
Even several months after COVID-19, one is still at an increased risk of blood clot and bleeding. In the worst case, a blood clot can be fatal; however, it can often be treated or prevented. These are the findings of a study from Umeå University, Sweden, where researchers analyzed all COVID-19 cases in Sweden from the start of the pandemic until May last year.
Page 1 of 16.
This course is organized by DANDRITE for PhD students enrolled in one of the four Partnership nodes (DANDRITE, MIMS, FIMM and NCMM). Other students…
The rapid developments of imaging technologies in the last two decades have led the scientific community to achieve biological and medical discoveries…
Members of EMBL Partnerships will convene in Heidelberg, Germany.
Members of the Nordic EMBL Partnership for Molecular Medicine will be hosted in Helsinki in 2023 for the Annual Meeting. Program and more information…
Researchers from FIMM review how human genetics can inform the biology and epidemiology of COVID-19 by pinpointing causal mechanisms that explain why some individuals become more severely affected by the disease upon infection by SARS-CoV-2 virus.
Researchers from Umeå University, Sweden, analyzed all COVID-19 cases in Sweden from the start of the pandemic until May last year and determined that COVID-19 is a risk factor for deep vein thrombosis, pulmonary embolism, and bleeding.
This study from researchers at MIMS and their collaborators, published in PloS Pathogens opens up new ways of selectively eradicating intracellular infection, proposing the inhibition of alaninol formation as a novel way of acting on infections caused by Salmonella.
Researchers from the Institute for Molecular Medicine Finland (FIMM) and collaborators at Helsinki Institute for Information Technology (HIIT) present a new computational platform, ScType, for cell profiling based single-cell RNA-sequencing data. They also demonstrate how it distinguishes between healthy and malignant cells, making it a versatile tool also for cancer applications. Open access through a web-based interface or as an open source R-package.
The female sex hormone oestrogen may have some protective effect against becoming seriously ill and dying in COVID-19, according to a registry study conducted at Umeå University. If so, this could explain why men are more likely than women to die during the pandemic.
An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine. The groundbreaking study helps researchers better understand the biological basis of migraine and its subtypes and could speed up the search for new treatment of the condition, which affects over a billion individuals worldwide.
Analysing molecular characteristics and their variation during lifestyle changes, by combining digital tools, classical laboratory tests and new biomolecular measurements, could enable individualised prevention of disease. This is according to a new study from Karolinska Institutet in Sweden and the University of Helsinki in Finland published in the journal Cell Systems. The researchers show what a proactive healthcare model could comprise and how it could help in maintaining good health.
A group of Nordic researchers has discovered a novel immune deficiency disease affecting the regulation of the immune system. A mutation in the IKZF2 gene was identified in a Finnish family with recurrent infections and signs of immune overactivation. The results provide a basis for a deeper understanding of the molecular mechanisms behind activation and maturation of T cells and will aid the diagnosis of rare inborn errors of immunity. doi: 10.1126/sciimmunol.abe3454
A functional precision medicine study conducted in Finland demonstrates that treatment selection based on results from drug sensitivity testing of patients' cells can be clinically useful in patients with aggressive hematological cancers.
Latest work from the Bionanotechnology and Membrane Systems group, led by Irep Gözen, has been shared in two pre-prints.
Page 1 of 4.
